ARIDIS PHARMACEUTICALS INC's ticker is ARDS and the CUSIP is 040334104. A total of 1 filers reported holding ARIDIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $98,205 | -30.0% | 446,588 | 0.0% | 0.19% | -39.3% |
| Q1 2023 | $140,273 | -73.4% | 446,588 | 0.0% | 0.32% | -75.6% |
| Q4 2022 | $526,974 | +27.0% | 446,588 | 0.0% | 1.30% | +45.3% |
| Q3 2022 | $415,000 | -15.5% | 446,588 | 0.0% | 0.90% | -6.1% |
| Q2 2022 | $491,000 | -37.5% | 446,588 | 0.0% | 0.96% | -24.7% |
| Q1 2022 | $786,000 | -24.5% | 446,588 | 0.0% | 1.27% | -8.5% |
| Q4 2021 | $1,041,000 | -18.6% | 446,588 | +28.5% | 1.39% | -18.1% |
| Q3 2021 | $1,279,000 | -36.7% | 347,517 | +27.3% | 1.69% | -28.2% |
| Q2 2021 | $2,019,000 | +54.0% | 272,886 | +22.8% | 2.36% | +24.5% |
| Q1 2021 | $1,311,000 | – | 222,222 | – | 1.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 272,886 | $2,019,000 | 2.36% |
| AIGH Capital Management LLC | 459,261 | $3,331,000 | 0.60% |
| Worth Venture Partners, LLC | 105,413 | $780,000 | 0.29% |
| PERRITT CAPITAL MANAGEMENT INC | 16,000 | $118,000 | 0.06% |
| Minot Wealth Management LLC | 25,000 | $152,000 | 0.03% |
| Newbridge Financial Services Group, Inc. | 400 | $3,000 | 0.00% |
| UBS Group AG | 3,229 | $24,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,271 | $9,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 750 | $6,000 | 0.00% |